688639 华恒生物
已收盘 06-22 15:00:01
资讯
新帖
简况
【新股IPO】华恒生物通过港交所主板上市聆讯
金吾财讯 · 01:15
【新股IPO】华恒生物通过港交所主板上市聆讯
华恒生物（688639）披露H股发行上市相关议案及章程修订事项，6月22日股价上涨0.62%
证券之星 · 06-22 22:43
华恒生物（688639）披露H股发行上市相关议案及章程修订事项，6月22日股价上涨0.62%
每周股票复盘：华恒生物（688639）2025年增收不增利，净利降30.13%
证券之星 · 06-20
每周股票复盘：华恒生物（688639）2025年增收不增利，净利降30.13%
股市必读：新发布《兴业证券股份有限公司关于安徽华恒生物科技股份有限公司关于2025年年度报告的信息披露监管问询函回复的核查意见》
证券之星 · 06-18
股市必读：新发布《兴业证券股份有限公司关于安徽华恒生物科技股份有限公司关于2025年年度报告的信息披露监管问询函回复的核查意见》
华恒生物（688639）披露关于2025年年度报告的信息披露监管问询函的回复公告，6月16日股价下跌0.66%
证券之星 · 06-16
华恒生物（688639）披露关于2025年年度报告的信息披露监管问询函的回复公告，6月16日股价下跌0.66%
华恒生物：H股发行上市已获中国证监会备案
证券之星 · 06-09
华恒生物：H股发行上市已获中国证监会备案
6月8日华恒生物跌5.94%，招商安瑞进取债券A基金重仓该股
证券之星 · 06-08
6月8日华恒生物跌5.94%，招商安瑞进取债券A基金重仓该股
华恒生物(688639.SH)：香港联交所审议公司发行H股
智通财经 · 06-07
华恒生物(688639.SH)：香港联交所审议公司发行H股
股市必读：华恒生物（688639）今年截至6月2日累计跌幅已超30%
证券之星 · 06-03
股市必读：华恒生物（688639）今年截至6月2日累计跌幅已超30%
阿洛酮糖装备商欧尚元冲刺创业板：拟募资12.51亿元，实控人掌握超八成表决权 | 长三角资本局
长三角资本局 · 06-01
阿洛酮糖装备商欧尚元冲刺创业板：拟募资12.51亿元，实控人掌握超八成表决权 | 长三角资本局
新股前瞻|行业下行、盈利失速，华恒生物(688639.SH)能否靠“出海”破局？
智通财经 · 05-27
新股前瞻|行业下行、盈利失速，华恒生物(688639.SH)能否靠“出海”破局？
股市必读：华恒生物（688639）今年截至5月25日累计跌幅已超25%
证券之星 · 05-26
股市必读：华恒生物（688639）今年截至5月25日累计跌幅已超25%
股市必读：华恒生物（688639）今年截至5月18日累计跌幅已超20%
证券之星 · 05-19
股市必读：华恒生物（688639）今年截至5月18日累计跌幅已超20%
每周股票复盘：华恒生物（688639）推进H股上市进程
证券之星 · 05-10
每周股票复盘：华恒生物（688639）推进H股上市进程
华恒生物（688639）披露发行H股并上市进展公告，5月6日股价下跌1.07%
证券之星 · 05-06
华恒生物（688639）披露发行H股并上市进展公告，5月6日股价下跌1.07%
每周股票复盘：华恒生物（688639）每股派现0.16元（含税）
证券之星 · 05-02
每周股票复盘：华恒生物（688639）每股派现0.16元（含税）
新股消息 | 华恒生物(688639.SH)递表港交所
智通财经 · 05-01
新股消息 | 华恒生物(688639.SH)递表港交所
每周股票复盘：华恒生物（688639）股东户数减少13.68%，一季报净利降17.61%
证券之星 · 04-26
每周股票复盘：华恒生物（688639）股东户数减少13.68%，一季报净利降17.61%
华恒生物（688639）2026年一季报简析：增收不增利，公司应收账款体量较大
证券之星 · 04-24
华恒生物（688639）2026年一季报简析：增收不增利，公司应收账款体量较大
华恒生物(688639.SH)发布一季度业绩，归母净利润4210万元，同比下降17.61%
智通财经 · 04-23
华恒生物(688639.SH)发布一季度业绩，归母净利润4210万元，同比下降17.61%
暂无数据
公司概况
公司名称：
安徽华恒生物科技股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2021-04-22
主营业务：
安徽华恒生物科技股份有限公司的主营业务是生物基产品的研发、生产、销售。公司的主要产品是氨基酸系列产品、维生素系列产品、生物基新材料单体、其他产品。
发行价格：
23.16
{"stockData":{"symbol":"688639","market":"SH","secType":"STK","nameCN":"华恒生物","latestPrice":21,"timestamp":1782111601000,"preClose":20.87,"halted":0,"volume":5988380,"delay":0,"changeRate":0.0062,"floatShares":250000000,"shares":250000000,"eps":0.4935,"marketStatus":"已收盘","change":0.13,"latestTime":"06-22 15:00:01","open":20.78,"high":21,"low":19.77,"amount":122000000,"amplitude":0.0589,"askPrice":21,"askSize":81,"bidPrice":20.98,"bidSize":55,"shortable":0,"etf":0,"ttmEps":0.4935,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782178200000},"marketStatusCode":5,"adr":0,"adjPreClose":20.87,"symbolType":"stock_kcb","openAndCloseTimeList":[[1782091800000,1782099000000],[1782104400000,1782111600000]],"highLimit":22.96,"lowLimit":18.78,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":250115693,"isCdr":false,"pbRate":1.95,"roa":"--","peRate":42.553191,"roe":"1.58%","epsLYR":0.53,"committee":0.254902,"marketValue":5252000000,"turnoverRate":0.0239,"status":0,"afterMarket":{"amount":0,"volume":0,"close":21,"buyVolume":0,"sellVolume":0,"time":1782113637746,"indexStatus":"已收盘 06-22 15:30:00","preClose":20.87},"floatMarketCap":5252000000},"requestUrl":"/m/hq/s/688639/tweets","defaultTab":"tweets","newsList":[{"id":"2645407130","title":"【新股IPO】华恒生物通过港交所主板上市聆讯","url":"https://stock-news.laohu8.com/highlight/detail?id=2645407130","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645407130?lang=zh_cn&edition=full","pubTime":"2026-06-23 01:15","pubTimestamp":1782148533,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据港交所6月22日文件，安徽华恒生物科技股份通过港交所主板上市聆讯，华泰国际为独家保荐人。截至2025年12月31日，公司已与包括亚洲、欧洲及美洲主要市场69个国家的超过815名客户建立稳定的长期合作关系。根据弗若斯特沙利文的资料，以2025年收入为衡量标准，公司L-丙氨酸及L-缬氨酸的市场份额分别位居全球第一。股东层面，郭恒华、郭恒平为一致行动人，合计控制30.78%表决权，为实控人与控股股东。","market":"sg","thumbnail":"https://static.szfiu.com/news/20220324/ODFiZjIzMmMyMWE2ZjBhMTAzMDA1NjgwOTQz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/ODFiZjIzMmMyMWE2ZjBhMTAzMDA1NjgwOTQz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984248","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688639","HEXmain","BK0229","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645734290","title":"华恒生物（688639）披露H股发行上市相关议案及章程修订事项，6月22日股价上涨0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645734290","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645734290?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:43","pubTimestamp":1782139396,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘，华恒生物报收于21.0元，较前一交易日上涨0.62%，最新总市值为52.52亿元。近日，安徽华恒生物科技股份有限公司发布《第五届董事会第五次会议决议公告》。会议同意公司H股全球发售及上市相关安排，包括批准发售事项、签署招股说明书、授权相关人员处理发行事务等。根据2025年第二次临时股东大会授权，上述议案无需提交股东大会审议。表决结果均为9票同意，0票反对，0票弃权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200039117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644065030","title":"每周股票复盘：华恒生物（688639）2025年增收不增利，净利降30.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644065030","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644065030?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:23","pubTimestamp":1781896988,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，华恒生物报收于20.87元，较上周的21.2元下跌1.56%。华恒生物就上交所问询函作出回复，确认2025年营收28.62亿元，净利1.32亿元，增收不增利主要由于产品价格下跌及期间费用上升。兴业证券发布核查意见指出，华恒生物2025年营业收入为28.62亿元，同比增长31.40%；归母净利润为1.32亿元，同比减少30.13%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000002006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644230497","title":"股市必读：新发布《兴业证券股份有限公司关于安徽华恒生物科技股份有限公司关于2025年年度报告的信息披露监管问询函回复的核查意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2644230497","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644230497?lang=zh_cn&edition=full","pubTime":"2026-06-18 02:12","pubTimestamp":1781719934,"startTime":"0","endTime":"0","summary":"兴业证券股份有限公司关于安徽华恒生物科技股份有限公司关于2025年年度报告的信息披露监管问询函回复的核查意见华恒生物2025年实现营业收入28.62亿元，同比增长31.40%；归母净利润1.32亿元，同比下降30.13%；2026年一季度营收7.71亿元，同比增长12.26%；归母净利润4209.73万元，同比下降17.61%；净利润下滑主因产品价格下降、期间费用增加及毛利率收窄；公司回应了产能利用、毛利率变动、存货增长、递延所得税资产增加等问题，并披露了融资租赁、技术授权等事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800001652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0276","601377","BK0012","688639","BK0183","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643409763","title":"华恒生物（688639）披露关于2025年年度报告的信息披露监管问询函的回复公告，6月16日股价下跌0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643409763","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643409763?lang=zh_cn&edition=full","pubTime":"2026-06-16 22:30","pubTimestamp":1781620230,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，华恒生物报收于21.16元，较前一交易日下跌0.66%，最新总市值为52.92亿元。近日，安徽华恒生物科技股份有限公司发布《关于2025年年度报告的信息披露监管问询函的回复公告》。公告显示，公司就上海证券交易所对公司2025年年度报告出具的信息披露监管问询函中涉及的经营业绩、毛利率、固定资产、存货、递延所得税资产、预付账款、应收票据、融资租赁、产能及技术授权等问题作出逐项回复。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600044263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642527461","title":"华恒生物：H股发行上市已获中国证监会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2642527461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642527461?lang=zh_cn&edition=full","pubTime":"2026-06-09 18:27","pubTimestamp":1781000838,"startTime":"0","endTime":"0","summary":"公司发行境外上市外资股（H股）并在香港联交所主板上市的相关工作正在有序推进中。公司已于2025年9月30日向香港联交所递交了本次发行并上市的申请，并于2026年4月30日更新递交本次发行并上市的申请；本次H股发行上市已获得中国证监会境外发行上市备案通知书。公司将严格按照境内外监管要求，及时履行信息披露义务，相关进展请以公司在上海证券交易所网站、指定信息披露媒体发布的公告为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900030025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641107197","title":"6月8日华恒生物跌5.94%，招商安瑞进取债券A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641107197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641107197?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:47","pubTimestamp":1780908443,"startTime":"0","endTime":"0","summary":"证券之星消息，6月8日华恒生物跌5.94%，收盘报20.57元，换手率2.97%，成交量7.44万手，成交额1.55亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为招商基金的招商安瑞进取债券A。招商安瑞进取债券A目前规模为20.97亿元，最新净值2.57，较上一交易日下跌0.04%，近一年上涨30.83%。招商安瑞进取债券A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800022321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641173761","title":"华恒生物(688639.SH)：香港联交所审议公司发行H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641173761","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641173761?lang=zh_cn&edition=full","pubTime":"2026-06-07 15:48","pubTimestamp":1780818503,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华恒生物(688639.SH)发布公告，公司正在进行申请发行境外上市股份(H股)并在香港联交所主板挂牌上市的相关工作。香港联交所上市委员会于2026年6月4日举行上市聆讯，审议公司本次发行上市的申请。公司本次发行上市的保荐人已于2026年6月5日收到香港联交所向其发出的信函，其中指出香港联交所上市委员会已审阅公司的上市申请，但该信函不构成正式的上市批准，香港联交所仍有对公司的上市申请提出进一步意见的权力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451103.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640479249","title":"股市必读：华恒生物（688639）今年截至6月2日累计跌幅已超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640479249","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640479249?lang=zh_cn&edition=full","pubTime":"2026-06-03 01:29","pubTimestamp":1780421351,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，华恒生物报收于22.51元，下跌4.5%，换手率2.46%，成交量6.14万手，成交额1.4亿元。当日关注点来自交易信息汇总：华恒生物股价已连续7日下跌，当日主力资金净流出2031.15万元，占总成交额14.53%。交易信息汇总股价提醒6月2日华恒生物收盘报22.51元，跌4.5%，当日成交1.4亿元。该股已连续7日下跌，年内累计跌幅33.32%。前10个交易日主力资金累计净流出1.16亿元，期间股价累计下跌22.26%；融资余额累计减少5494.9万元，融券余量累计增加2.23万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300001733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640987227","title":"阿洛酮糖装备商欧尚元冲刺创业板：拟募资12.51亿元，实控人掌握超八成表决权 | 长三角资本局","url":"https://stock-news.laohu8.com/highlight/detail?id=2640987227","media":"长三角资本局","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640987227?lang=zh_cn&edition=full","pubTime":"2026-06-01 11:10","pubTimestamp":1780283400,"startTime":"0","endTime":"0","summary":" 5月28日，深交所官网显示，欧尚元智能装备股份有限公司创业板IPO获受理，公司拟募集资金约12.51亿元，投向生物制造核心装备生产基地建设项目、分离纯化系统制造中心改造及智能化升级项目、研发中心建设项目等。截至2025年末，公司阿洛酮糖领域在手订单总额突破3.5亿元。 整体来看，欧尚元此次冲刺创业板，踩中的是生物制造产业化加速的窗口。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/csjzbj/2026-06-01/doc-inhzwisw4145636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0196","LU2289578879.USD","LU1580142542.USD","688639","LU1655091616.SGD","BK0188","CIIHY","BK0226","LU0405327494.USD","BK0012","LU1997245177.USD","600030","BK0183","LU1997244956.HKD","06030","LU1064130708.USD","LU1781817850.SGD","LU2495084118.USD","LU0405327148.USD","LU1997245094.SGD","605016","BK0276","LU1328615791.USD","BK0028","LU1064131003.USD","LU2148510915.USD","LU1255011170.USD","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638527357","title":"新股前瞻|行业下行、盈利失速，华恒生物(688639.SH)能否靠“出海”破局？","url":"https://stock-news.laohu8.com/highlight/detail?id=2638527357","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638527357?lang=zh_cn&edition=full","pubTime":"2026-05-27 09:52","pubTimestamp":1779846753,"startTime":"0","endTime":"0","summary":"若本次成功登陆港股，华恒生物将形成“A+H”两地上市格局。此前，华恒生物已于2021年4月登陆A股科创板。在行业供需失衡、价格竞争加剧的宏观背景下，华恒生物此番冲刺港股，能否获得市场认可，尚待时间检验。2024年按收入计，华恒生物L-丙氨酸及L-缬氨酸的市场份额均位居全球第一，确立了其在细分领域的领先地位。根据招股书披露，华恒生物本次募资将主要用于深化全球布局、海外研发能力建设及海外产能建设。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446406.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638517845","title":"股市必读：华恒生物（688639）今年截至5月25日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638517845","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638517845?lang=zh_cn&edition=full","pubTime":"2026-05-26 01:30","pubTimestamp":1779730232,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，华恒生物报收于25.44元，下跌0.62%，换手率1.33%，成交量3.32万手，成交额8501.35万元。当日关注点来自交易信息汇总：华恒生物股价已连续3日下跌，当日主力资金净流出1158.58万元，占总成交额13.63%。交易信息汇总5月25日华恒生物收盘报25.44元，跌0.62%，当日成交331.69万元。该股已连续3日下跌，当年累计跌幅25.22%。近90天内共有8家机构给出评级，买入评级5家，增持评级2家，中性评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600001240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636008157","title":"股市必读：华恒生物（688639）今年截至5月18日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636008157","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636008157?lang=zh_cn&edition=full","pubTime":"2026-05-19 01:24","pubTimestamp":1779125051,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，华恒生物报收于26.47元，下跌2.36%，换手率2.12%，成交量5.31万手，成交额1.43亿元。当日关注点来自交易信息汇总：华恒生物股价连续7日下跌，当日主力资金净流入1169.93万元，但散户资金净流出1439.7万元。交易信息汇总股价提醒5月18日华恒生物收盘报26.47元，跌2.36%，当日成交530.79万元。该股已连续7日下跌，当年累计跌幅21.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900001924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634841453","title":"每周股票复盘：华恒生物（688639）推进H股上市进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2634841453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634841453?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:22","pubTimestamp":1778350933,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，华恒生物报收于27.41元，较上周的28.0元下跌2.11%。本周，华恒生物5月6日盘中最高价报28.49元。华恒生物当前最新总市值68.56亿元，在化学制品板块市值排名67/171，在两市A股市值排名2819/5200。本周关注点公司公告汇总：华恒生物已更新H股上市申请材料并提交至香港联交所。公司公告汇总安徽华恒生物科技股份有限公司正在推进发行境外上市股份（H股）并在香港联合交易所主板上市的相关工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633839091","title":"华恒生物（688639）披露发行H股并上市进展公告，5月6日股价下跌1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633839091","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633839091?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:32","pubTimestamp":1778059975,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，华恒生物报收于27.7元，较前一交易日下跌1.07%，最新总市值为69.28亿元。该股当日开盘28.0元，最高28.49元，最低27.63元，成交额达1.55亿元，换手率为2.21%。安徽华恒生物科技股份有限公司于近日披露《关于发行H股并上市的进展公告》。公告显示，公司正在推进发行境外上市股份（H股）并在香港联合交易所主板上市的相关工作。本次发行尚需获得香港证监会及香港联交所等监管机构的批准，存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600027547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632628370","title":"每周股票复盘：华恒生物（688639）每股派现0.16元（含税）","url":"https://stock-news.laohu8.com/highlight/detail?id=2632628370","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632628370?lang=zh_cn&edition=full","pubTime":"2026-05-02 05:16","pubTimestamp":1777670176,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，华恒生物报收于28.0元，较上周的27.82元上涨0.65%。本周，华恒生物4月30日盘中最高价报28.65元。本周关注点公司公告汇总：华恒生物每股派发现金红利0.16元（含税），股权登记日为2026年5月11日。本次利润分配以总股本250,115,693股扣减回购股份496,600股为基数，合计派发现金红利39,939,054.88元（含税）。截至核查意见出具日，总股本为250,115,693股，参与分配股份数量为249,619,093股。保荐机构兴业证券对此事项无异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632691162","title":"新股消息 | 华恒生物(688639.SH)递表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2632691162","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632691162?lang=zh_cn&edition=full","pubTime":"2026-05-01 11:49","pubTimestamp":1777607350,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据港交所2026年4月30日披露，安徽华恒生物科技股份有限公司(简称：华恒生物(688639.SH))向港交所提交上市申请书，华泰国际为独家保荐人。招股书显示，华恒生物为全球首家实现系列氨基酸(包括L-丙氨酸及L-缬氨酸)厌氧发酵法产业化的企业，以2024年收入为衡量标准，公司L-丙氨酸及L-缬氨酸的市场份额分别位居全球第一。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437607.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0229","688639","IPOS","HEXmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630802858","title":"每周股票复盘：华恒生物（688639）股东户数减少13.68%，一季报净利降17.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630802858","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630802858?lang=zh_cn&edition=full","pubTime":"2026-04-26 04:37","pubTimestamp":1777149428,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，华恒生物报收于27.82元，较上周的28.06元下跌0.86%。本周，华恒生物4月23日盘中最高价报29.66元。华恒生物当前最新总市值69.58亿元，在化学制品板块市值排名64/171，在两市A股市值排名2695/5200。本周关注点股本股东变化：股东户数较上期减少13.68%，户均持股上升至1.95万股。股本股东变化股东户数变动截至2026年3月31日，公司股东户数为1.28万户，较2月28日减少2035.0户，减幅13.68%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629584046","title":"华恒生物（688639）2026年一季报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2629584046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629584046?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:28","pubTimestamp":1777040923,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期华恒生物发布2026年一季报。截至本报告期末，公司营业总收入7.71亿元，同比上升12.26%，归母净利润4209.73万元，同比下降17.61%。本报告期华恒生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达199.82%。本次财报公布的各项数据指标表现一般。持有华恒生物最多的基金为招商安瑞进取债券A，目前规模为20.97亿元，最新净值2.6572，较上一交易日下跌0.77%，近一年上涨41.34%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400065156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629026934","title":"华恒生物(688639.SH)发布一季度业绩，归母净利润4210万元，同比下降17.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629026934","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629026934?lang=zh_cn&edition=full","pubTime":"2026-04-23 00:27","pubTimestamp":1776875257,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华恒生物(688639.SH)披露2026年第一季度报告，报告期公司实现营收7.71亿元，同比增长12.26%;归母净利润4210万元，同比下降17.61%;扣非净利润4213万元，同比下降16.92%。基本每股收益0.17元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432313.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782156439273,"stockEarnings":[{"period":"1week","weight":-0.0141},{"period":"1month","weight":-0.1797},{"period":"3month","weight":-0.2806},{"period":"6month","weight":-0.391},{"period":"1year","weight":-0.3239},{"period":"ytd","weight":-0.3517}],"compareEarnings":[{"period":"1week","weight":0.0161},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0726},{"period":"6month","weight":0.0564},{"period":"1year","weight":0.2391},{"period":"ytd","weight":0.0489}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽华恒生物科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"12837人(较上一季度减少13.68%)","perCapita":"19483股","listingDate":"2021-04-22","address":"安徽省合肥市长丰县双凤工业区","registeredCapital":"25011万元","survey":" 安徽华恒生物科技股份有限公司的主营业务是生物基产品的研发、生产、销售。公司的主要产品是氨基酸系列产品、维生素系列产品、生物基新材料单体、其他产品。","listedPrice":23.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华恒生物,688639,华恒生物股票,华恒生物股票老虎,华恒生物股票老虎国际,华恒生物行情,华恒生物股票行情,华恒生物股价,华恒生物股市,华恒生物股票价格,华恒生物股票交易,华恒生物股票购买,华恒生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}